A Phase I Multicenter Study of Continuous Oral Administration of Lonafarnib (SCH 66336) and Intravenous Gemcitabine in Patients with Advanced Cancer

We conducted a phase I study to assess safety, pharmacokinetics, pharmacodynamics and activity of lonafarnib plus gemcitabine. Subjects received oral lonafarnib twice daily and gemcitabine on days 1, 8 and 15 every 28 days; multiple dose levels were explored. Lonafarnib had no apparent effect on gem...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wong, Nan Soon, Meadows, Kellen L., Rosen, Lee S., Adjei, Alex A., Kaufmann, Scott H., Morse, Michael A., Petros, William P., Zhu, Yali, Statkevich, Paul, Cutler, David L., Meyers, Michael L., Hurwitz, Herbert I.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4101887/
https://ncbi.nlm.nih.gov/pubmed/22011284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/07357907.2011.621912
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados